Next Article in Journal
COVID-19 Vaccination Safety and Tolerability in Patients Allegedly at High Risk for Immediate Hypersensitivity Reactions
Next Article in Special Issue
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera
Previous Article in Journal
Propensity-Score-Matched Evaluation of Adverse Events Affecting Recovery after COVID-19 Vaccination: On Adenovirus and mRNA Vaccines
Previous Article in Special Issue
Attenuation of Antibody Titers from 3 to 6 Months after the Second Dose of the BNT162b2 Vaccine Depends on Sex, with Age and Smoking Risk Factors for Lower Antibody Titers at 6 Months
 
 
Article

Article Versions Notes

Vaccines 2022, 10(2), 285; https://doi.org/10.3390/vaccines10020285
Action Date Notes Link
article xml file uploaded 13 February 2022 12:43 CET Original file -
article xml uploaded. 13 February 2022 12:43 CET Update https://www.mdpi.com/2076-393X/10/2/285/xml
article pdf uploaded. 13 February 2022 12:43 CET Version of Record https://www.mdpi.com/2076-393X/10/2/285/pdf
article supplementary file uploaded. 13 February 2022 12:43 CET - https://www.mdpi.com/2076-393X/10/2/285#supplementary
article html file updated 13 February 2022 12:44 CET Original file https://www.mdpi.com/2076-393X/10/2/285/html
Back to TopTop